Antioxidants and methimazole in the treatment of Graves' disease: effect on urinary malondialdehyde levels

التفاصيل البيبلوغرافية
العنوان: Antioxidants and methimazole in the treatment of Graves' disease: effect on urinary malondialdehyde levels
المؤلفون: Mirta Karner, José A. Burdman, Liliana Guerra, Silvia Moiguer, María del Carmen Ríos de Molina, Eliana A. Miler
المصدر: Clinica chimica acta; international journal of clinical chemistry. 352(1-2)
سنة النشر: 2004
مصطلحات موضوعية: Vitamin, HYPERTHYROIDISM, Adult, Male, medicine.medical_specialty, Antioxidant, CIENCIAS MÉDICAS Y DE LA SALUD, endocrine system diseases, medicine.medical_treatment, Urinary system, Graves' disease, Clinical Biochemistry, Medicina Clínica, medicine.disease_cause, Biochemistry, Antioxidants, chemistry.chemical_compound, Double-Blind Method, Heart Rate, Internal medicine, Endocrinología y Metabolismo, Malondialdehyde, Medicine, MALONDIALDEHYDE, Humans, Euthyroid, METHIMAZOLE (MMI), Methimazole, business.industry, Vitamin E, Biochemistry (medical), General Medicine, Middle Aged, medicine.disease, Graves Disease, Oxidative Stress, Endocrinology, chemistry, Female, business, Oxidative stress, Follow-Up Studies
الوصف: We have postulated that metabolic oxidation could be the source of signs and symptoms of hyperthyroidism. The present study was designed to evaluate urinary malondialdehyde levels in Graves' disease and compare this oxidative stress biomarker with the clinical evolution of patients suffering this illness. We evaluated the concentration of urinary and serum malondialdehyde (MDA) in 36 patients with Graves' disease. Patients were treated with the antithyroid drug methimazole (MMI; Group A) or antioxidant mixture (200 mg vitamin E, 3 mg β-carotene, 250 mg vitamin C, 1 mg Cu, 7.5 mg Zn, 1.5 mg Mn, and 15 μg Se; Group B). MDA concentrations were higher in hyperthyroid patients compared to euthyroid controls, and a positive correlation was observed between serum and urinary MDA levels. Group A decreased urinary MDA to control values. There was a positive correlation between the clinical score and the heart rate of patients with urinary MDA before and during the treatment with MMI (Group A). Similar results were observed after treatment with the antioxidant mixture. Urinary MDA might be a good parameter in the follow-up of patients during MMI treatment. We proposed that oxidative stress correlates with signs and symptoms of hyperthyroidism. Fil: Guerra, Liliana Noemi. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Química Biológica; Argentina. Hospital Israelita; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Rios, Maria del Carmen. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Química Biológica; Argentina Fil: Miler, Eliana Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Química Biológica; Argentina Fil: Moiguer, Silvia. Hospital Israelita; Argentina Fil: Karner, Mirta. Hospital Israelita; Argentina Fil: Burdman, Jose Adolfo. Universidad Abierta Interamericana; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Hospital Israelita; Argentina
وصف الملف: application/pdf
تدمد: 0009-8981
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c687463955a430698f478a90705574
https://pubmed.ncbi.nlm.nih.gov/15653105
حقوق: RESTRICTED
رقم الأكسشن: edsair.doi.dedup.....56c687463955a430698f478a90705574
قاعدة البيانات: OpenAIRE